Nova Cannabis Inc.

As of June 30, 2024, Nova Cannabis Inc. has 57.33M shares outstanding.

As of June 30, 2024, Nova Cannabis Inc. trades at a trailing price-to-earnings ratio of 24.12. The price-to-sales ratio is 0.27, and the price-to-book ratio stands at 1.33.

As of June 30, 2024, Nova Cannabis Inc. trades at an EV/EBITDA multiple of 5.38 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.46 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 10.64 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Nova Cannabis Inc. trades at an EV/FCF ratio of 5.45, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of June 30, 2024, Nova Cannabis Inc. maintains a current ratio of 1.96, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 105.32, indicating elevated leverage, while an interest coverage ratio of 4.89 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2024, Nova Cannabis Inc. posted a return on equity (ROE) of 6.01, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 10.12 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.47, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 6.89, useful for judging operating efficiency across full business cycles. Inventory turnover of 13.07 indicates how many times Nova Cannabis Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2024, Nova Cannabis Inc. posted a gross margin of 24.83, reflecting its pricing power and cost economics. The operating margin of 4.32 and net profit margin of 1.14 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2024. Free cash flow yield stands at 24.22, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 8.29, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Nova Cannabis Inc. shareholders.

Nova Cannabis Inc.'s most recent stock split took place on March 24, 2021 with a 500:27 split ratio.

As of June 30, 2024, Nova Cannabis Inc. has an Altman Z-Score of 3.03, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.